Navigation Links
Study Puts 1 Alzheimer's Theory in Doubt

Results in mice suggest a key gene might not be to blame, researchers say

MONDAY, Aug. 20 (HealthDay News) -- Research with mice is poking holes in a prevailing theory on the origins of Alzheimer's, scientists say.

Mice without a gene thought to rein in cell-damaging free radicals actually had fewer Alzheimer's-linked brain plaques than mice with the gene.

"This finding may go beyond Alzheimer's into all aging theory," noted lead researcher Carlos T. Moraes, an associate professor of neurology and cell biology and anatomy at the University of Miami Miller School of Medicine.

The study is published in this week's early edition of the journal Proceedings of the National Academy of Sciences.

Moraes said that, right now, "nobody knows what causes Alzheimer's disease," which affects more than 4.5 million Americans according to the National Institutes of Health.

However, one leading hypothesis is that there is a defect in the mitochondrial energy production system in cells, Moraes explained. The mitochondria are the cell's "power houses," giving it the energy it needs to function.

In prior studies, examination of the brain cells of people with Alzheimer's found some defects in an enzyme produced by the cytochrome c oxidase (COX) gene, which is important for mitochondrial energy production.

In addition, so-called "free radicals," which cause oxidative stress, are produced in the cell's mitochondria, Moraes noted. "It was assumed that when you have a problem with the COX gene, you have more free radicals being formed," he said.

To see how the gene worked, Moraes's group removed the COX10 gene in mice engineered to develop Alzheimer's disease.

"We expected to see that these animals would have more amyloid plaques," Moraes said. "But we got the opposite result," he said.

The animals without the COX10 gene actually developed fewer brain plaques than those with the gene, Moraes said. "Those animals also had less free radicals," he said.

The findings suggest that a defect in the COX10 gene develops after amyloid plaques develop, not the other way around, as has been thought, Moraes said.

"The mitochondrial defect in Alzheimer's disease appears to be a consequence of amyloid accumulation, not the cause of amyloid accumulation," he said. "Also, if you have a defect in the COX gene, you are not necessarily going to have more free radicals being formed," he added.

According to Moraes, the finding could have implications for scientists' understanding of the aging brain in general, not just Alzheimer's.

If the findings are duplicated in other research, they might be useful in developing new treatments for Alzheimer's -- treatments that target the COX gene, Moraes said.

One expert agreed that the findings shed new light on Alzheimer's disease.

"This study shows that a genetic manipulation that reduced the activity of a key energy-producing enzyme also reduced free radical damage and Alzheimer pathology in a mouse model," said Greg M. Cole, a neuroscientist at the Greater Los Angeles VA Healthcare System and associate director of the Alzheimer's Disease Research Center at UCLA's David Geffen School of Medicine.

"The results are consistent with other evidence that reducing free radicals can limit Alzheimer amyloid plaque pathology," Cole added. "Examples include reducing caloric intake or increasing antioxidant intake. So, even though clinical trials to treat Alzheimer's with [antioxidant] vitamin E have been disappointing, earlier and more effective reduction of free radical damage could mimic the success of this genetic approach and should still be pursued," he said.

More information

For more on Alzheimer's disease, visit the Alzheimer's Association.

SOURCES: Carlos T. Moraes, Ph.D., associate professor, neurology and cell biology and anatomy, University of Miami Miller School of Medicine, Florida; Greg M. Cole, Ph.D., neuroscientist, Greater Los Angeles VA Healthcare System, and associate director, Alzheimer's Disease Research Center, UCLA David Geffen School of Medicine, Los Angeles; Aug. 20-24, 2007, early edition, Proceedings of the National Academy of Sciences


Copyright©2007 ScoutNews,LLC.

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain medications ... from Austin, Texas, has identified a solution. , She developed a prototype for MOTION ... As such, it eliminates the need to turn on a light when taking medication ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
Breaking Medicine Technology: